Cogent Biosciences, Inc. (COGT): Price and Financial Metrics
COGT Price/Volume Stats
| Current price | $9.08 | 52-week high | $12.61 |
| Prev. close | $9.06 | 52-week low | $3.67 |
| Day low | $8.93 | Volume | 1,934,600 |
| Day high | $9.30 | Avg. volume | 1,434,011 |
| 50-day MA | $10.89 | Dividend yield | N/A |
| 200-day MA | $8.79 | Market Cap | 1.00B |
COGT Stock Price Chart Interactive Chart >
Cogent Biosciences, Inc. (COGT) Company Bio
Unum Therapeutics Inc., a biopharmaceutical company, focuses on developing a pipeline of novel therapies to treat cancer patients. The company's novel proprietary technology, known as Bolt-On Chimeric Receptor (BOXR), is designed to improve the functionality of engineered T cells by discovering and incorporating a Âbolt-on' transgene into a patients' engineered T cells to overcome resistance of the solid tumor microenvironment to T cell attack. Its advanced program, PLX9486, is a selective KIT D816V inhibitor that is being developed to treat patients with systemic mastocytosis and gastrointestinal stromal tumors. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.
COGT Price Returns
| 1-mo | -25.82% |
| 3-mo | -10.81% |
| 6-mo | 10.46% |
| 1-year | 39.26% |
| 3-year | -1.30% |
| 5-year | 284.75% |
| YTD | 54.42% |
| 2023 | -49.13% |
| 2022 | 34.73% |
| 2021 | -23.60% |
| 2020 | 289.82% |
| 2019 | N/A |
Loading social stream, please wait...